MeSH D010024 - osteoporosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Accord Healthcare | Teriparatide | Sondelbay |  | 2022-03-24 |  |  |
| Eli Lilly | Teriparatide | Forsteo |  | 2003-06-10 |  |  |
| EuroGenerics | Teriparatide | Qutavina |  | 2020-08-27 |  |  |
| Fresenius Kabi | Medium chain triglycerides | Smoflipid |  | 2016-07-13 |  |  |
| Gedeon Richter | Teriparatide | Terrosa |  | 2017-01-04 |  |  |
| Organon | Alendronate, Cholecalciferol | Fosamax D |  | 2005-04-07 |  |  |
| Sandoz | Zoledronic acid | Aclasta |  | 2005-04-15 |  |  |
| Folic acid, Dexpanthenol, Ascorbic acid, Cyanocobalamin, Vitamin a, Alpha-tocopherol, Biotin, Cholecalciferol, Niacinamide, Pyridoxine, Riboflavin, Thiamine, Tocopherol | Infuvite |  | 2000-05-18 |  |  | |
| Stada Arzneimittel | Teriparatide | Movymia |  | 2017-01-11 |  |  |
| Strides Pharma Global | Teriparatide | Kauliv |  | 2023-01-12 |  |  |
| Sun Pharmaceutical Industries | Teriparatide | Teriparatide Sun |  | 2022-11-18 |  |  |
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
60%26/43
Phase 2
63%27/43
Phase 3
63%32/51
Approved: 6Overall Success rate: 24%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use